CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $0.36 ($3,626)
- 4 Open-market buy SVP Corp Dev & Gen Counsel bought 15,000 shares at $0.37 ($5,550)
- 4 Open-market buy Chief Financial Officer bought 21,000 shares at $0.36 ($7,560)
- 4 Open-market buy President, Chief Executive Off bought 26,800 shares at $0.37 ($9,857)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 250,000 shares at $0.20 ($50,000)
- 4 Open-market buy Director bought 500,000 shares at $0.20 ($100,000)
- 4 Open-market buy Director bought 150,000 shares at $0.20 ($30,000)
- 4 Open-market buy President, Chief Executive Off bought 149,000 shares at $0.20 ($29,800)
- 4 Open-market buy Chief Financial Officer bought 87,500 shares at $0.20 ($17,500)
- 4 Open-market buy VP Corp Dev & Gen Counsel bought 75,000 shares at $0.20 ($15,000)
- 4 Open-market buy Director bought 7,260 shares at $1.60 ($11,616)
Page 9 of 19 · 373 filings